Pars plana vitrectomy with intravitreal triamcinolone: Effect on uveitic cystoid macular oedema and treatment limitations

British Journal of Ophthalmology

Volumn 91, Issue 3, 2007, Pages 345-348

  Gutfleisch, Matthias ^a   Spital, Georg ^a   Mingels, Anne ^a   Pauleikhoff, Daniel ^a   Lommatzsch, Albrecht ^a   Heiligenhaus, Arnd ^a  

^a ST FRANZISKUS HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; CORTICOSTEROID DERIVATIVE; TRIAMCINOLONE ACETONIDE; GLUCOCORTICOID;

ADOLESCENT; ADULT; AGED; ARTICLE; CATARACT; CILIARY DISK; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAOCULAR HYPERTENSION; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETINA MACULA CYSTOID EDEMA; TONOMETRY; TREATMENT OUTCOME; UVEITIS; VISUAL ACUITY; VITRECTOMY; EVALUATION; INJECTION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; RETROSPECTIVE STUDY; VITREOUS BODY;

ADOLESCENT; ADULT; AGED; CATARACT; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INJECTIONS; MACULAR EDEMA, CYSTOID; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; UVEITIS; VISUAL ACUITY; VITRECTOMY; VITREOUS BODY;

EID: 33947583919     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2006.101675     Document Type: Article

References (49)

1. Rothova A, Suttorp-van Schulten MS, Frits Treffers W, et al. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 1996;80:332-6.
2. Schilling H, Pauleikhoff D, Schrenk M, et al. Therapy of cystoid diffuse macular edema after uveitis and cataract surgery with the carbonic anhydrase inhibitor acetazolamide (Diamox). Klin Monatsbl Augenheilkd 1993;202:206-11.
3. Farber MD, Lam S, Tessler HH, et al. Reduction of macular oedema by acetazolamide in patients with chronic iridocyclitis: a randomised prospective crossover study. Br J Ophthalmol 1994;78:4-7.
4. Whitcup SM, Csaky KG, Podgor MJ, et al. A randomized, masked, cross-over trial of acetazolamide for cystoid macular edema in patients with uveitis. Ophthalmology 1996;103:1054-62.
5. Cox SN, Hay E, Bird AC. Treatment of chronic macular edema with acetazolamide. Arch Ophthalmol 1988;106:1190-5.
6. Zierhut M, Thiel HJ, Schlote T. Treatment of uveitic macular edema with acetazolamide. Doc Ophthalmol 1999;97:409-13.
7. Rojas B, Zafirakis P, Christen W, et al. Medical treatment of macular edema in patients with uveitis. Doc Ophthalmol 1999;97:399-407.
8. Riordan-Eva P, Lightman S. Orbital floor steroid injections in the treatment of uveitis. Eye 1994;8(Pt 1):66-9.
9. Lightman S. Use of steroids and immunosuppressive drugs in the management of posterior uveitis. Eye 1991;5(Pt 3):294-8.
10. Antcliff RJ, Spalton DJ, Stanford MR, et al. Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology 2001;108:765-72.
11. Yazici H, Pazarli H, Barnes CG, et al. A controlled trial of azathioprine in Behcet's syndrome. N Engl J Med 1990;322:281-5.
12. Nussenblatt RB, Palestine AG, Chan CC, et al. Randomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endogenous uveitis. Am J Ophthalmol 1991;112:138-46.
13. Holz FG, Krastel H, Breitbart A, et al. Low-dose methotrexate treatment in noninfectious uveitis resistant to corticosteroids. Ger J Ophthalmol 1992;1:142-4.
14. Ozyazgan Y, Yurdakul S, Yazici H, et al. Low dose cyclosporin A versus pulsed cyclophosphamide in Behcet's syndrome: a single masked trial. Br J Ophthalmol 1992;76:241-3.
15. Larkin G, Lightman S. Mycophenolate mofetil. A useful immunosuppressive in inflammatory eye disease. Ophthalmology 1999;106:370-4.
16. Sloper CM, Powell RJ, Dua HS. Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporine. Ophthalmology 1999;106:723-8.
17. Samson CM, Waheed N, Baltatzis S, et al. Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients. Ophthalmology 2001;108:1134-9.
18. Eckardt C, Bacskulin A. Vitrectomy in intermediate uveitis. Dev Ophthalmol 1992;23:232-8.
19. Heimann K, Schmanke L, Brunner R, et al. Pars plana vitrectomy in the treatment of chronic uveitis. Dev Ophthalmol 1992;23:196-203.
20. Heiligenhaus A, Bornfeld N, Wessing A. Long-term results of pars plana vitrectomy in the management of intermediate uveitis. Curr Opin Ophthalmol 1996;7:77-9.
21. Verbraeken H. Therapeutic pars plana vitrectomy for chronic uveitis: a retrospective study of the long-term results. Graefes Arch Clin Exp Ophthalmol 1996;234:288-93.
22. Dugel PU, Rao NA, Ozler S, et al. Pars plana vitrectomy for intraocular inflammation-related cystoid macular edema unresponsive to corticosteroids. A preliminary study. Ophthalmology 1992;99:1535- 41.
23. Kiryu J, Kita M, Tanabe T, et al. Pars plana vitrectomy for cystoid macular edema secondary to sarcoid uveitis. Ophthalmology 2001;108:1140-4.
24. Wiechens B, Nolle B, Reichelt JA. Pars-plana vitrectomy in cystoid macular edema associated with intermediate uveitis. Graefes Arch Clin Exp Ophthalmol 2001;239:474-81.
25. Martidis A, Duker JS, Puliafito CA. Intravitreal triamcinolone for refractory cystoid macular edema secondary to birdshot retinochoroidopathy. Arch Ophthalmol 2001;119:1380-3.
26. Young S, Larkin G, Branley M, et al. Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Exp Ophthalmol 2001;29:2-6.
27. Degenring RF, Jonas JB. Intravitreal injection of triamcinolone acetonide as treatment for chronic uveitis. Br J Ophthalmol 2003;87:361.
28. Karacorlu M, Mudun B, Ozdemir H, et al. Intravitreal triamcinolone acetonide for the treatment of cystoid macular edema secondary to Behcet disease. Am J Ophthalmol 2004;138:289-91.
29. Bloch-Michel E, Nussenblatt RB. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol 1987;103:234-5.
30. Schilling H, Heiligenhaus A, Laube T, et al. Long-term effect of acetazolamide treatment of patients with uveitic chronic cystoid macular edema is limited by persisting inflammation. Retina 2005;25:182-8.
31. Chylach LT Jr, Wolfe JK, Singer DM, et al. The Lens Opacities Classification System III. The Longtitudinal Cataract Study Group. Arch Ophthalmol 1993;111:831-6.
32. Helm CJ, Holland GN. The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis. Am J Ophthalmol 1995;120:55-64.
33. Tanner V, Kanski JJ, Frith PA. Posterior sub-Tenon's triamcinolone injections in the treatment of uveitis. Eye 1998;12(Pt 4):679-85.
34. Okada AA, Wakabayashi T, Morimura Y, et al. Trans-Tenon's retrobulbar triamcinolone infusion for the treatment of uveitis. Br J Ophthalmol 2003;87:968-71.
35. Wakefield D, McCluskey P, Penny R. Intravenous pulse methylprednisolone therapy in severe inflammatory eye disease. Arch Ophthalmol 1986;104:847-51.
36. Tehrani NN, Saeed T, Murray PI. Deep intramuscular methylprednisolone for the treatment of cystoid macular oedema in uveitis. Eye 2000;14(Pt 5):691-4.
37. Nussenblatt RB, Palestine AG, Chan CC. Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents. Am J Ophthalmol 1983;96:275-82.
38. Heiligenhaus A, Bornfeld N, Foerster MH, et al. Long-term results of pars plana vitrectomy in the management of complicated uveitis. Br J Ophthalmol 1994;78:549-54.
39. Kroll P, Romstock F, Grenzebach UH, et al. Early vitrectomy in endogenous juvenile uveitis intermedia - a long-term study. Klin Monatsbl Augenheilkd 1995;206:246-9.
40. Sorensen TL, Haamann P, Villumsen J, et al. Intravitreal triamcinolone for macular oedema: efficacy in relation to aetiology. Acta Ophthalmol Scand 2005;83:67-70.
41. Schindler RH, Chandler D, Thresher R, et al. The clearance of intravitreal triamcinolone acetonide. Am J Ophthalmol 1982;93:415-17.
42. Beer PM, Bakri SJ, Singh RJ, et al. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 2003;110:681-6.
43. Chin HS, Park TS, Moon YS, et al. Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes. Retina 2005;25:556-60.
44. Sonoda KH, Enaida H, Ueno A, et al. Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series study. Br J Ophthalmol 2003;87:1010-14.
45. Recchia FM, Ruby AJ, Carvalho Recchia CA. Pars plana vitrectomy with removal of the internal limiting membrane in the treatment of persistent diabetic macular edema. Am J Ophthalmol 2005;139:447-54.
46. Rosenblatt BJ, Shah GK, Sharma S, et al. Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid. Graefes Arch Clin Exp Ophthalmol 2005;243:20-5.
47. Gandorfer A, Messmer EM, Ulbig MW, et al. Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane. Retina 2000;20:126-33.
48. Wiechens B, Reichelt JA, Urbat C, et al. Pars plana vitrectomy in cystoid macular edema of different forms of chronic uveitis. Ophthalmologe 2003;100:33-43.
49. Jonas JB, Degenring RF, Kreissig I, et al. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Ophthalmology 2005;112:593-8.